MicroRNA-424通过增加转录因子的表达减轻小鼠缺血性脑损伤

目的研究microRNA-424（miR-424）对小鼠脑缺血后神经细胞凋亡及转录因子表达的影响。方法将制备的慢病毒Lenti-miR-424（10’U／mL,8斗L）通过脑室注射,7d后采用大脑中动脉线栓闭塞（MCAO）的方法建立小鼠脑缺血模型,动物分4组：假手术组,假手术＋miR-424慢病毒,MCAO模型组,MCAO＋miR-424慢病毒处理组（n=6）。缺血8h后取脑组织,石蜡切片进行TUNEL染色,观察神经细胞凋亡的情况;Westernblot检测缺血脑组织中转录因子Pu．1、低氧诱导因子-la（hypoxiainduciblefactor-1a,HIF-1a）、凋亡相关蛋白p53的表达。结果TUNEL免疫荧光观察结果显示,miR-424可以减轻小鼠脑缺血后8h的神经细胞凋亡;Westernblot结果显示,在缺血前和缺血8h后,miR-424对正常小鼠或MCAO模型脑组织中转录因子的调节趋势是相同的,均增加转录因子PU．1蛋白、HIF．1a蛋白、以及凋亡相关蛋白p53的表达。结论miR-424可能通过增加小鼠脑组织转录因子PU．1和HIF-la,以及凋亡相关蛋白p53的表达,从而减轻脑缺血后神经细胞的凋亡。     

具有广泛抗病毒活性的SAMHD1蛋白的研究进展

SAMHD1蛋白是2011年首次被认定为一种独特的天然抗病毒因子,它主要在树突状细胞、巨噬细胞等髓系细胞中表达。它通过降解细胞内dNTPs的水平,使细胞内的dNTPs的水平低于病毒复制所需的水平,从而抑制髓系细胞中反转录病毒和DNA病毒的复制。HIV-2产生的病毒蛋白X(Vpx)可将泛素连接酶与SAMHD1相结合,使SAMHD1分子最后被蛋白酶体降解。最近还发现SAMHD1蛋白活性受多种因子影响,具有调节肿瘤细胞中LINE-1活性的功能。结合最新研究成果对SAMHD1的结构、功能、抗病毒机制以及影响因子进行综述。     

Rev蛋白: 抗HIV-1感染的新靶点

病毒颗粒蛋白表达调节因子(regulatorofvirionproteinexpression,Rev)是HIV-1转录过程中不可缺少的调控蛋白。Rev与病毒mRNA的Rev应答元件(revresponseelement,RRE)相互作用,加速mRNA向核外转运。Rev缺乏或者不能进入细胞核,未剪接和部分剪接的mRNA将在核内完全降解,导致HIV-1的复制被阻断。Rev在HIV-1复制周期中起着重要的反式调节作用,是寻找新作用机制和不易产生耐药性的抗艾滋病药物的新靶点。该文介绍Rev介导的核质转运过程和Rev蛋白的相关抑制剂。     

单纯疱疹病毒1型VP16蛋白和VHS蛋白研究进展

单纯疱疹病毒1型(HSV-1)为有包膜的DNA病毒,能引起皮肤性疱疹、角膜炎、脑炎等症状.HSV-1感染细胞后,要么进入裂解性感染阶段,要么进入潜伏感染阶段.受感染的细胞常会启动免疫系统抵抗病毒,而病毒却通过某种机制巧妙地逃避宿主的免疫反应并进入潜伏.进入潜伏感染阶段的病毒又会因机体受某种刺激而被激活进入裂解感染期.在这期间,有两个关键的病毒蛋白一间层蛋白(Viral protein 16,VP16)和内膜蛋白(Virion host shutoff protein,VHS)倍受关注,它们既是HSV-1的结构蛋白,在病毒复制晚期参与病毒颗粒的组装,同时又作为重要的功能蛋白,在病毒感染早期发挥重要的转录调节功能.下面就这两个蛋白相关功能的研究进展作一简要综述:     

杏仁核SIRT1对慢性束缚应激大鼠抑郁样行为的影响

目的:观察杏仁核沉默信息调节因子1(SIRT1)蛋白对慢性束缚应激(CRS)大鼠抑郁样行为的影响。方法:60只SD雄性大鼠随机分为6组(n=10):正常对照组(Control)、慢性束缚应激组(CRS)、CRS+氟西汀(FLU)组(CRS+FLU)、CRS+生理盐水组(CRS+NaCl)、CRS+SIRT1过表达组(CRS+AAV-SIRT1)和CRS+空载体组(CRS+AAV-EGFP)。除了正常对照组,其余各组均接受慢性束缚应激造模21 d。造模结束后,氟西汀组和生理盐水组大鼠每天分别灌胃给予氟西汀(10 mg/kg)或生理盐水(10 mg/kg),持续3周;SIRT1过表达组和空载体组大鼠分别脑立体定位,注射腺相关病毒AAV-SIRT1或AAV-EGFP于杏仁核,待病毒表达3周;正常组和抑郁症组大鼠则不给予任何药物。应用糖水偏好实验(SPT)、旷场实验(OFT)和强迫游泳实验(FST)检测各组大鼠的抑郁样行为学变化;蛋白免疫印迹实验检测大鼠杏仁核中SIRT1蛋白的表达;免疫荧光技术检测大鼠杏仁核中SIRT1阳性细胞数量。结果:与正常对照组相比,CRS抑郁大鼠杏仁核中SIRT1蛋白...     

人星状病毒Ⅰ型非结构蛋白nsP1a及其C末端蛋白nsP1a/4的原核表达及鉴定

人星状病毒(Human Astrovirus,HastV)是导致婴幼儿腹泻的重要病原体。HastV非结构蛋白nsP1a及C末端蛋白nsP1a/4含有各种保守的功能结构域,在星状病毒的复制、转录,病毒与宿主的相互作用中起重要作用。为获得nsP1a及其nsP1a/4蛋白,为后续蛋白相关研究提供平台,本研究在E.coli系统中进行人星状病毒非结构蛋白nsP1a及nsP1a/4蛋白的表达并对表达产物进行鉴定。首先将nsP1a及nsP1a/4基因克隆入原核表达载体PGEX-4T-1,构建nsP1a及nsP1a/4蛋白融合表达质粒;在E.coli BL21(DE3)中进行IPTG诱导表达,摸索两种融合蛋白表达的最优条件并对表达蛋白进行免疫印迹鉴定。结果表明nsP1a蛋白在30℃,1mM IPTG诱导12h时,蛋白表达量达到最高;nsP1a/4蛋白在20℃,0.5mM IPTG诱导8h时,蛋白表达量达到最高。Western blot结果显示两种融合蛋白既可与nsP1a蛋白免疫血清发生特异性反应,也可被GST标签抗体所识别。本研究成功利用原核系统表达并鉴定了人星状病毒非结构蛋白nsP1a及其C末端蛋白nsP1a/4,为进一步研究星状病毒非结构蛋白的功能及病毒的致病机制奠定基础。     

水稻Os着-c op 1基因的原核表达及多克隆抗体制备

着-COP蛋白是真核生物分泌途径中COP玉有被小泡的一个亚基。本研究利用PCR技术扩增水稻着-c op基因(Os着-c op 1)的ORF(开放阅读框),并克隆到原核表达载体pET-23d上,将表达载体pET-Os着-cop1转入大肠杆菌BL21(DE3),以1.0 mmol/L的IPTG (isopropylβ-D-thiogalactoside)诱导表达重组蛋白,然后以重组蛋白作为抗原免疫家兔,制备多克隆抗体。SDS-PAGE电泳分析结果表明,成功诱导表达了分子量约为35 kD的重组蛋白,Western blot检测表明,免疫家兔的抗血清与水稻幼穗总蛋白杂交信号较好。Os着-COP1抗体的制备有助于研究该基因及COPI小泡在水稻中的功能。     

程序性细胞死亡因子4与单纯疱疹病毒US3蛋白相互作用及参与细胞凋亡

程序性细胞死亡因子-4（programmed celld eath-4,PDCD4）通过阻断相关基因的转录与翻译从而抑制肿瘤发生,单纯疱疹病毒-1（herpes simplex virus-1,HSV-1）US3蛋白激酶可有效调控病毒基因产物或外源因素引致的细胞凋亡。近期研究证明PDCD4在病毒感染细胞中以US3依赖及非依赖两种模式被磷酸化修饰,其中受US3修饰的PDCD4仍定位细胞核并随之被降解,这可能是细胞凋亡被抑制的主要原因之一,此外,PDCD4沉默可阻断复制不完全病毒引致的细胞凋亡,表明PDCD4与HSV-1 US3阻断细胞凋亡途径直接相关。本文综述了这两种蛋白及其作用关系的研究进展,为解析病毒与细胞相互作用机理提供新方向。     

寨卡病毒NS1的结构研究进展及其应用

寨卡病毒感染与小头畸形和神经系统并发症紧密相关,甚至可能损伤男性生殖系统,引起了全球性的关注,研究其结构和致病机制以及开发有效的诊断治疗方法成为当务之急。寨卡病毒的非结构蛋白NS1是病毒与宿主相互作用的重要蛋白,在病毒复制、发病机制及免疫逃逸中起着关键作用。本文总结了寨卡病毒NS1的空间精细结构,并将其与其它黄病毒NS1进行比较。本文也分析了寨卡病毒基于NS1的致病机理,总结了NS1在疾病诊断中的应用。     

禽流感病毒H5N1亚型NS1蛋白的研究进展

NS1蛋白（non—structural protein1）是A型流感病毒重要的非结构蛋白,作为流感病毒的致病因子,NS1通过多种方式增强病毒的致病性和毒力。就H5N1禽流感病毒NS1蛋白的结构与功能进行了综述。     

ARFGAP1 promotes AP-2-dependent endocytosis

COPI (coat protein I) and the clathrin-AP-2 (adaptor protein 2) complex are well-characterized coat proteins, but a component that is common to these two coats has not been identified. The GTPase-activating protein (GAP) for ADP-ribosylation factor 1 (ARF1), ARFGAP1, is a known component of the COPI complex. Here, we show that distinct regions of ARFGAP1 interact with AP-2 and coatomer (components of the COPI complex). Selectively disrupting the interaction of ARFGAP1 with either of these two coat proteins leads to selective inhibition in the corresponding transport pathway. The role of ARFGAP1 in AP-2-regulated endocytosis has mechanistic parallels with its roles in COPI transport, as both its GAP activity and coat function contribute to promoting AP-2 transport.     

Physical aspects of COPI vesicle formation

Abstract

Coat proteins orchestrate membrane budding and molecular sorting during the formation of transport intermediates. Coat protein complex I (COPI) vesicles shuttle between the Golgi apparatus and the endoplasmic reticulum and between Golgi stacks. The formation of a COPI vesicle proceeds in four steps: coat self-assembly, membrane deformation into a bud, fission of the coated vesicle and final disassembly of the coat to ensure recycling of coat components. Although some issues are still actively debated, the molecular mechanisms of COPI vesicle formation are now fairly well understood. In this review, we argue that physical parameters are critical regulators of COPI vesicle formation. We focus on recent real-time in vitro assays highlighting the role of membrane tension, membrane composition, membrane curvature and lipid packing in membrane remodelling and fission by the COPI coat.     

Segregation of COPI-rich and anterograde-cargo-rich domains in endoplasmic-reticulum-to-Golgi transport complexes.

Membrane traffic between the endoplasmic reticulum (ER) and the Golgi complex is regulated by two vesicular coat complexes, COPII and COPI. COPII has been implicated in the selective packaging of anterograde cargo into coated transport vesicles budding from the ER [1]. In mammalian cells, these vesicles coalesce to form tubulo-vesicular transport complexes (TCs), which shuttle anterograde cargo from the ER to the Golgi complex [2] [3] [4]. In contrast, COPI-coated vesicles are proposed to mediate recycling of proteins from the Golgi complex to the ER [1] [5] [6] [7]. The binding of COPI to COPII-coated TCs [3] [8] [9], however, has led to the proposal that COPI binds to TCs and specifically packages recycling proteins into retrograde vesicles for return to the ER [3] [9]. To test this hypothesis, we tracked fluorescently tagged COPI and anterograde-transport markers simultaneously in living cells. COPI predominated on TCs shuttling anterograde cargo to the Golgi complex and was rarely observed on structures moving in directions consistent with retrograde transport. Furthermore, a progressive segregation of COPI-rich domains and anterograde-cargo-rich domains was observed in the TCs. This segregation and the directed motility of COPI-containing TCs were inhibited by antibodies that blocked COPI function. These observations, which are consistent with previous biochemical data [2] [9], suggest a role for COPI within TCs en route to the Golgi complex. By sequestering retrograde cargo in the anterograde-directed TCs, COPI couples the sorting of ER recycling proteins [10] to the transport of anterograde cargo.     

ARFGAP2 and ARFGAP3 Are Essential for COPI Coat Assembly on the Golgi Membrane of Living Cells

Coat protein complex I (COPI) vesicles play a central role in the recycling of proteins in the early secretory pathway and transport of proteins within the Golgi stack. Vesicle formation is initiated by the exchange of GDP for GTP on ARF1 (ADP-ribosylation factor 1), which, in turn, recruits the coat protein coatomer to the membrane for selection of cargo and membrane deformation. ARFGAP1 (ARF1 GTPase-activating protein 1) regulates the dynamic cycling of ARF1 on the membrane that results in both cargo concentration and uncoating for the generation of a fusion-competent vesicle. Two human orthologues of the yeast ARFGAP Glo3p, termed ARFGAP2 and ARFGAP3, have been demonstrated to be present on COPI vesicles generated in vitro in the presence of guanosine 5′-3-O-(thio)triphosphate. Here, we investigate the function of these two proteins in living cells and compare it with that of ARFGAP1. We find that ARFGAP2 and ARFGAP3 follow the dynamic behavior of coatomer upon stimulation of vesicle budding in vivo more closely than does ARFGAP1. Electron microscopy of ARFGAP2 and ARFGAP3 knockdowns indicated Golgi unstacking and cisternal shortening similarly to conditions where vesicle uncoating was blocked. Furthermore, the knockdown of both ARFGAP2 and ARFGAP3 prevents proper assembly of the COPI coat lattice for which ARFGAP1 does not seem to play a major role. This suggests that ARFGAP2 and ARFGAP3 are key components of the COPI coat lattice and are necessary for proper vesicle formation.     

ArfGAP1 Activity and COPI Vesicle Biogenesis

Golgi-derived coat protein I (COPI) vesicles mediate transport in the early secretory pathway. The minimal machinery required for COPI vesicle formation from Golgi membranes in vitro consists of (i) the hetero-heptameric protein complex coatomer, (ii) the small guanosine triphosphatase ADP-ribosylation factor 1 (Arf1) and (iii) transmembrane proteins that function as coat receptors, such as p24 proteins. Various and opposing reports exist on a role of ArfGAP1 in COPI vesicle biogenesis. In this study, we show that, in contrast to data in the literature, ArfGAP1 is not required for COPI vesicle formation. To investigate roles of ArfGAP1 in vesicle formation, we titrated the enzyme into a defined reconstitution assay to form and purify COPI vesicles. We find that catalytic amounts of Arf1GAP1 significantly reduce the yield of purified COPI vesicles and that Arf1 rather than ArfGAP1 constitutes a stoichiometric component of the COPI coat. Combining the controversial reports with the results presented in this study, we suggest a novel role for ArfGAP1 in membrane trafficking.     

Arf1-GTP-induced tubule formation suggests a function of Arf family proteins in curvature acquisition at sites of vesicle budding

ADP-ribosylation factor (Arf) and related small GTPases play crucial roles in membrane traffic within the exo- and endocytic pathways. Arf proteins in their GTP-bound state are associated with curved membrane buds and tubules, frequently together with effector coat proteins to which they bind. Here we report that Arf1 is found on membrane tubules originating from the Golgi complex where it colocalizes with COPI and GGA1 vesicle coat proteins. Arf1 also induces tubulation of liposomes in vitro. Mutations within the amino-terminal amphipathic helix (NTH) of Arf1 affect the number of Arf1-positive tubules in vivo and its property to tubulate liposomes. Moreover, hydrophilic substitutions within the hydrophobic part of its NTH impair Arf1-catalyzed budding of COPI vesicles in vitro. Our data indicate that GTP-controlled local induction of high curvature membranes is an important property of Arf1 that might be shared by a subgroup of Arf/Arl family GTPases.     

Rsp5 ubiquitin ligase is required for protein trafficking in Saccharomyces cerevisiae COPI mutants

Retrograde trafficking from the Golgi to the endoplasmic reticulum (ER) depends on the formation of vesicles coated with the multiprotein complex COPI. In Saccharomyces cerevisiae ubiquitinated derivatives of several COPI subunits have been identified. The importance of this modification of COPI proteins is unknown. With the exception of the Sec27 protein (β'COP) neither the ubiquitin ligase responsible for ubiquitination of COPI subunits nor the importance of this modification are known. Here we find that the ubiquitin ligase mutation, rsp5-1, has a negative effect that is additive with ret1-1 and sec28Δ mutations, in genes encoding α- and ε-COP, respectively. The double ret1-1 rsp5-1 mutant is also more severely defective in the Golgi-to-ER trafficking compared to the single ret1-1, secreting more of the ER chaperone Kar2p, localizing Rer1p mostly to the vacuole, and increasing sensitivity to neomycin. Overexpression of ubiquitin in ret1-1 rsp5-1 mutant suppresses vacuolar accumulation of Rer1p. We found that the effect of rsp5 mutation on the Golgi-to-ER trafficking is similar to that of sla1Δ mutation in a gene encoding actin cytoskeleton proteins, an Rsp5p substrate. Additionally, Rsp5 and Sla1 proteins were found by co-immunoprecipitation in a complex containing COPI subunits. Together, our results show that Rsp5 ligase plays a role in regulating retrograde Golgi-to-ER trafficking.     

ER arrival sites for COPI vesicles localize to hotspots of membrane trafficking

COPI‐coated vesicles mediate retrograde membrane traffic from the cis‐Golgi to the endoplasmic reticulum (ER) in all eukaryotic cells. However, it is still unknown whether COPI vesicles fuse everywhere or at specific sites with the ER membrane. Taking advantage of the circumstance that the vesicles still carry their coat when they arrive at the ER, we have visualized active ER arrival sites (ERAS) by monitoring contact between COPI coat components and the ER‐resident Dsl tethering complex using bimolecular fluorescence complementation (BiFC). ERAS form punctate structures near Golgi compartments, clearly distinct from ER exit sites. Furthermore, ERAS are highly polarized in an actin and myosin V‐dependent manner and are localized near hotspots of plasma membrane expansion. Genetic experiments suggest that the COPI?Dsl BiFC complexes recapitulate the physiological interaction between COPI and the Dsl complex and that COPI vesicles are mistargeted in dsl1 mutants. We conclude that the Dsl complex functions in confining COPI vesicle fusion sites.     

Essential lysine residues within transmembrane helix 1 of diphtheria toxin facilitate COPI binding and catalytic domain entry

The translocation of the diphtheria toxin catalytic domain from the lumen of early endosomes into the cytosol of eukaryotic cells is an essential step in the intoxication process. We have previously shown that the in vitro translocation of the catalytic domain from the lumen of toxin pre‐loaded endosomal vesicles to the external medium requires the addition of cytosolic proteins including coatomer protein complex I (COPI) to the reaction mixture. Further, we have shown that transmembrane helix 1 plays an essential, but as yet undefined role in the entry process. We have used both site‐directed mutagenesis and a COPI complex precipitation assay to demonstrate that interaction(s) between at least three lysine residues in transmembrane helix 1 are essential for both COPI complex binding and the delivery of the catalytic domain into the target cell cytosol. Finally, a COPI binding domain swap was used to demonstrate that substitution of the lysine‐rich transmembrane helix 1 with the COPI binding portion of the p23 adaptor cytoplasmic tail results in a mutant that displays full wild‐type activity. Thus, irrespective of sequence, the ability of transmembrane helix 1 to bind to COPI complex appears to be the essential feature for catalytic domain delivery to the cytosol.     

ARFGAP1 plays a central role in coupling COPI cargo sorting with vesicle formation

Examining how key components of coat protein I (COPI) transport participate in cargo sorting, we find that, instead of ADP ribosylation factor 1 (ARF1), its GTPase-activating protein (GAP) plays a direct role in promoting the binding of cargo proteins by coatomer (the core COPI complex). Activated ARF1 binds selectively to SNARE cargo proteins, with this binding likely to represent at least a mechanism by which activated ARF1 is stabilized on Golgi membrane to propagate its effector functions. We also find that the GAP catalytic activity plays a critical role in the formation of COPI vesicles from Golgi membrane, in contrast to the prevailing view that this activity antagonizes vesicle formation. Together, these findings indicate that GAP plays a central role in coupling cargo sorting and vesicle formation, with implications for simplifying models to describe how these two processes are coupled during COPI transport.